The Federal Circuit limits the reach of the on sale bar and provides guidance to pharmaceutical companies that rely on the use of contract manufacturers. Bruce Haas and Lauren Zuffante discuss.
Related Services
Related Insights
Supreme Court Hears Argument on the Constitutionality of Administrative Patent Judge Appointments in United States v. Arthrex
Supreme Court Hears Argument on the Constitutionality of Administrative Patent Judge Appointments in United States v. Arthrex
March 02, 2021
12min
Third Circuit Panel Revises Half-Baked Trade Dress Functionality Decision
Third Circuit Panel Revises Half-Baked Trade Dress Functionality Decision
February 03, 2021
5min
The Trademark Modernization Act: Real Change to Address the Realities of Trademark Law
The Trademark Modernization Act: Real Change to Address the Realities of Trademark Law
February 02, 2021
5min
Recent News
Venable Client Novartis Prevails Against Motion for Judgment on the Pleadings in the Entresto® Patent Litigation
Venable Client Novartis Prevails Against Motion for Judgment on the Pleadings in the Entresto® Patent Litigation
February 26, 2021
2min
Michael Klein Joins Venable’s Environmental and Natural Resources Group in Washington, DC
Michael Klein Joins Venable’s Environmental and Natural Resources Group in Washington, DC
February 25, 2021
2min
Venable Launches Wellbrand™ Naming Solutions
Venable Launches Wellbrand™ Naming Solutions
February 25, 2021
4min